Publication | Closed Access

Intermediate-length polyglutamine in ATXN2 is a possible risk factor among Eastern Chinese patients with amyotrophic lateral sclerosis

Neurodegenerative DiseasesEastern Chinese PatientsMolecular NeuroscienceAmyotrophic Lateral SclerosisNeurological DisorderDegenerative DiseaseIntermediate-length PolyglutamineNeurochemical BiomarkersNeurologyNeuroscienceNeuropathologyMedicineSocial SciencesNeurogenetics